Blood test study aims to predict chemo success for breast cancer
NCT ID NCT06087120
Summary
This study aims to learn if a simple blood test can help doctors predict how well chemotherapy will work for breast cancer. It will observe 125 women with stage II or III breast cancer before, during, and after their standard chemotherapy treatment. Researchers will check for tiny pieces of tumor DNA in the blood and compare them to MRI scans to see which method better predicts a patient's response to treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MRCCC Siloam Hospitals Semanggi
RECRUITINGJakarta, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical Genetics Institute
RECRUITINGHo Chi Minh City, Vietnam
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Medical Center HCMC
RECRUITINGHo Chi Minh City, Vietnam
Contact
Contact
Conditions
Explore the condition pages connected to this study.